Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Active Ingredients
  • Bevacizumab

Bevacizumab

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
abevmy
Bevacizumab
Biosimilar Collaborations Ireland Limited
Alymsys 25 mg/mL concentrate for solution for infusion
No Recent Update
SPC PIL No A
Bevacizumab
Zentiva Pharma UK Limited
Avastin 25 mg/ml concentrate for solution for infusion
Updated
SPC PIL No A
Bevacizumab
Roche Registration GmbH
avzivi
Bevacizumab
FGK Representative Service GmbH
aybintio
Bevacizumab
Samsung Bioepis NL B.V.
MVASI
No Recent Update
SPC PIL No A
Bevacizumab
Amgen Ireland Ltd
oyavas
Bevacizumab
STADA Arzneimittel AG
Vegzelma 25 mg/mL concentrate for solution for infusion
No Recent Update
SPC PIL No A
Bevacizumab
Celltrion Healthcare Ireland Ltd.
Zirabev 25 mg/ml concentrate for solution for infusion
No Recent Update
SPC PIL No A
Bevacizumab
Pfizer Healthcare Ireland Unlimited Company

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
This medicine and its document have not been updated in the last 30 days.
Black Inverted Triangle: This medicinal product is subject to additional monitoring.
Product subject to medical prescription which may not be renewed (A)
Documents associated with this medicine were updated in the last 30 days.
The Summary of Product Characteristics (SPC) is a specific document, the wording of which has been agreed with the regulatory authority as part of the medicine approval process. It is required before any medicine is allowed on the market in Europe. It is designed to assist doctors and pharmacists in prescribing and supplying the product.
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
''Company'' may refer to either the Marketing Authorization Holder (MAH), the company responsible for marketing the product in Ireland and/or responsible for uploading documents pertaining to the product onto Medicines.ie. To determine the MAH, please consult the actual submitted documents.